Cargando…

The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer

Cancer-associated fibroblasts (CAFs) are implicated in the strong malignancy of pancreatic cancer (PC). Various CAF subtypes have different functions, and their heterogeneity likely influence the malignancy of PC. Meanwhile, it is known that senescent cells can create a tumor-promoting microenvironm...

Descripción completa

Detalles Bibliográficos
Autores principales: Higashiguchi, Masaya, Murakami, Hirotomo, Akita, Hirofumi, Kobayashi, Shogo, Takahama, Shokichi, Iwagami, Yoshifumi, Yamada, Daisaku, Tomimaru, Yoshito, Noda, Takehiro, Gotoh, Kunihito, Doki, Yuichiro, Yamamoto, Takuya, Eguchi, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091076/
https://www.ncbi.nlm.nih.gov/pubmed/36999632
http://dx.doi.org/10.3892/or.2023.8535
_version_ 1785023081469706240
author Higashiguchi, Masaya
Murakami, Hirotomo
Akita, Hirofumi
Kobayashi, Shogo
Takahama, Shokichi
Iwagami, Yoshifumi
Yamada, Daisaku
Tomimaru, Yoshito
Noda, Takehiro
Gotoh, Kunihito
Doki, Yuichiro
Yamamoto, Takuya
Eguchi, Hidetoshi
author_facet Higashiguchi, Masaya
Murakami, Hirotomo
Akita, Hirofumi
Kobayashi, Shogo
Takahama, Shokichi
Iwagami, Yoshifumi
Yamada, Daisaku
Tomimaru, Yoshito
Noda, Takehiro
Gotoh, Kunihito
Doki, Yuichiro
Yamamoto, Takuya
Eguchi, Hidetoshi
author_sort Higashiguchi, Masaya
collection PubMed
description Cancer-associated fibroblasts (CAFs) are implicated in the strong malignancy of pancreatic cancer (PC). Various CAF subtypes have different functions, and their heterogeneity likely influence the malignancy of PC. Meanwhile, it is known that senescent cells can create a tumor-promoting microenvironment by inducing a senescence-associated secretory phenotype (SASP). In the present study, the effects of individual differences in CAFs on PC malignancy were investigated with a focus on cellular senescence. First, primary cultures of CAFs from 8 PC patients were generated and co-cultured with PC cell lines. This co-culture assay showed that differences in CAFs induce differences in PC cell proliferation. It was further investigated which clinical factors affected the malignant potential of CAF and it was found that the difference of malignant potential of each CAF was marginally related to the age of original patients. Next, to verify the senescence of CAFs really affected the malignant potential of CAF, PCR array analysis of each CAF sample was performed and it was revealed that expression of genes about cellular senescence and SASP such as tumor protein p53, nuclear factor kappa B subunit 1, and IL6, are related to the malignant potential of CAFs impacting on PC proliferation. Finally, to elucidate the effect of p53-mediated cellular senescence of CAFs on malignant potential of PC, it was examined whether CAFs with the treatment of p53 inhibitor affected PC cell proliferation in co-culture assays. The treatment of CAFs with p53 inhibitor significantly suppressed PC cell proliferation. In addition, a comparison of the concentration of IL-6, a SASP cytokine, in the co-culture supernatant showed a significant decrease in the sample after p53 inhibitor treatment. In conclusion, the present results suggested that proliferation potential of PC may be related to p53-mediated cellular senescence and SASP of CAFs.
format Online
Article
Text
id pubmed-10091076
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-100910762023-04-13 The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer Higashiguchi, Masaya Murakami, Hirotomo Akita, Hirofumi Kobayashi, Shogo Takahama, Shokichi Iwagami, Yoshifumi Yamada, Daisaku Tomimaru, Yoshito Noda, Takehiro Gotoh, Kunihito Doki, Yuichiro Yamamoto, Takuya Eguchi, Hidetoshi Oncol Rep Articles Cancer-associated fibroblasts (CAFs) are implicated in the strong malignancy of pancreatic cancer (PC). Various CAF subtypes have different functions, and their heterogeneity likely influence the malignancy of PC. Meanwhile, it is known that senescent cells can create a tumor-promoting microenvironment by inducing a senescence-associated secretory phenotype (SASP). In the present study, the effects of individual differences in CAFs on PC malignancy were investigated with a focus on cellular senescence. First, primary cultures of CAFs from 8 PC patients were generated and co-cultured with PC cell lines. This co-culture assay showed that differences in CAFs induce differences in PC cell proliferation. It was further investigated which clinical factors affected the malignant potential of CAF and it was found that the difference of malignant potential of each CAF was marginally related to the age of original patients. Next, to verify the senescence of CAFs really affected the malignant potential of CAF, PCR array analysis of each CAF sample was performed and it was revealed that expression of genes about cellular senescence and SASP such as tumor protein p53, nuclear factor kappa B subunit 1, and IL6, are related to the malignant potential of CAFs impacting on PC proliferation. Finally, to elucidate the effect of p53-mediated cellular senescence of CAFs on malignant potential of PC, it was examined whether CAFs with the treatment of p53 inhibitor affected PC cell proliferation in co-culture assays. The treatment of CAFs with p53 inhibitor significantly suppressed PC cell proliferation. In addition, a comparison of the concentration of IL-6, a SASP cytokine, in the co-culture supernatant showed a significant decrease in the sample after p53 inhibitor treatment. In conclusion, the present results suggested that proliferation potential of PC may be related to p53-mediated cellular senescence and SASP of CAFs. D.A. Spandidos 2023-03-27 /pmc/articles/PMC10091076/ /pubmed/36999632 http://dx.doi.org/10.3892/or.2023.8535 Text en Copyright: © Higashiguchi et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Higashiguchi, Masaya
Murakami, Hirotomo
Akita, Hirofumi
Kobayashi, Shogo
Takahama, Shokichi
Iwagami, Yoshifumi
Yamada, Daisaku
Tomimaru, Yoshito
Noda, Takehiro
Gotoh, Kunihito
Doki, Yuichiro
Yamamoto, Takuya
Eguchi, Hidetoshi
The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
title The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
title_full The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
title_fullStr The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
title_full_unstemmed The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
title_short The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
title_sort impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091076/
https://www.ncbi.nlm.nih.gov/pubmed/36999632
http://dx.doi.org/10.3892/or.2023.8535
work_keys_str_mv AT higashiguchimasaya theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT murakamihirotomo theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT akitahirofumi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT kobayashishogo theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT takahamashokichi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT iwagamiyoshifumi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT yamadadaisaku theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT tomimaruyoshito theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT nodatakehiro theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT gotohkunihito theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT dokiyuichiro theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT yamamototakuya theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT eguchihidetoshi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT higashiguchimasaya impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT murakamihirotomo impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT akitahirofumi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT kobayashishogo impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT takahamashokichi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT iwagamiyoshifumi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT yamadadaisaku impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT tomimaruyoshito impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT nodatakehiro impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT gotohkunihito impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT dokiyuichiro impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT yamamototakuya impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer
AT eguchihidetoshi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer